MENU
ABCL
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AbCellera Biologics (ABCL) Ownership - Who owns AbCellera Biologics?
Profile
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
871.33M
P/E Ratio
N/A
Total Cash
643.14M
Projected Growth
N/A
Total Debt
71.4M
Revenue
32.96M
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash/Share
2.18
Total Debt/Equity
N/A
Revenue/Share
0.11 USD as % of share price
Fundamentals
ABCL
Capitalization
871M
P/E Ratio
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash
643M
Total Cash/Share
2.18
Total Debt
71.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.11%
Revenue
33M
ROE
N/A
Book Value
1.08B
P/B Ratio
0.81
Cash Flow
N/A
Earnings
-0.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
773M
Current Ratio
9.34
Current Revenue Per Employee
11104.10
Dividends Per Share - Security
N/A
EBITDA
-202.4M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-12.10
Shares Held By Institutions
4.94B
Shares Outstanding - Current
295M
Total Liabilities
315M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-48.336
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2215 Yukon Street
Phone
+1 604 559-9005
Employees
586
Web
https://www.abcellera.com